ROGER FARRIS: Open Payments
NPI 1902491558 · HIGHLAND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 47 payments from 17 companies in 2025. Trend: 2023 $436 · 2024 $598 · 2025 $888
Food & beverage: $873Education: $15
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $232 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $83 |
| ABBVIE INC. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $72 |
| Verona Pharma, Inc. | 3 | $59 |
| Exact Sciences Corporation | 3 | $52 |
| Lilly USA, LLC | 2 | $43 |
| Almatica Pharma LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
Products named: REXULTI, CAPLYTA, FANAPT, Ohtuvayre, Cologuard Collection Kit, MOUNJARO, LOREEV XR, VRAYLAR.
Industry payments across IN — which companies pay providers there.
